FIELD: medicine. SUBSTANCE: method involves administering enterosorbent during 10 days per os at a dose of 30 g twice a day not earlier than 1.5 h before taking meals and medicine. EFFECT: reduced risk of adverse side effects; enhanced effectiveness of treatment. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING THERAPEUTICALLY RESISTANT PATIENTS WITH SCHIZOPHRENIA | 1999 |
|
RU2177326C2 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| METHOD FOR ALLEVIATING COMPLICATED ABSTINENCE SYNDROME | 1992 |
|
RU2067442C1 |
| METHOD FOR PREDICTING TREATMENT EFFECTIVENESS IN PATIENTS SUFFERING FROM DEPRESSIVE DISORDERS CAUSED BY SELECTIVE SEROTONINERGIC ANTIDEPRESSANTS | 2000 |
|
RU2177253C1 |
| METHOD FOR PREDICTING NEGATIVE CLINICAL MANIFESTATIONS IN SCHIZOPHRENIA FLOW | 2001 |
|
RU2188577C1 |
| METHOD FOR TREATING PATIENTS WITH EXOGENIC-ORGANIC BRAIN LESION | 2001 |
|
RU2194489C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD OF CORRECTION OF PSYCHOPATHIC BEHAVIOR OF PERSONS SHOWING SCHIZOID PSYCHOPATHY | 1993 |
|
RU2094046C1 |
| AGENT FOR ALCOHOLIC ABSINENT SYNDROME ARRESTING | 2000 |
|
RU2167655C1 |
| METHOD OF EFFICIENCY FORECAST FOR RESIDUAL SHIZOPHRENIA TREATMENT BY ATYPICAL NEUROLEPTIC QUETIAPINE | 2007 |
|
RU2349918C1 |
